The Cancer-Immunity Cycle in Multiple Myeloma

por Casey, Mika, Nakamura, Kyohei
Publicado 2021

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA

por Casey, Mika, Tu, Cui, Harrison, Simon J., Nakamura, Kyohei
Publicado 2022

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma

por Sze, Jun Hui, Raninga, Prahlad V., Nakamura, Kyohei, Casey, Mika, Khanna, Kum Kum, Berners-Price, Susan J., Di Trapani, Giovanna, Tonissen, Kathryn F.
Publicado 2019